| |
 |
|
Class Information
Number: 424/260.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Pseudomonas (e.g., pseudomonas aeruginosa, etc.)
Description: Subject matter wherein the bacterium is of the genus Pseudomonas.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7556810 |
Compositions and methods to control angiogenesis with cupredoxins |
Jul. 7, 2009 |
| 7517533 |
Pseudomonas aeruginosa antigens |
Apr. 14, 2009 |
| 7459165 |
Polypeptides of Pseudomonas aeruginosa |
Dec. 2, 2008 |
| 7384639 |
Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
Jun. 10, 2008 |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7371394 |
Antigenic composition of a Pseudomonas aeruginosa protein |
May. 13, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7338794 |
Amended recombinant cells for the production and delivery of gamma interferon as an antiviral agent, adjuvant and vaccine accelerant |
Mar. 4, 2008 |
| 7314632 |
Pseudomonas exotoxin A-like chimeric immunogens |
Jan. 1, 2008 |
| 7268209 |
Peptides, derivates thereof, process for producing the same, novel strain producing the same, and antiviral agent comprising the same as active ingredient |
Sep. 11, 2007 |
| 7183100 |
Aconitase |
Feb. 27, 2007 |
| 7166270 |
Methods of screening compounds useful for prevention of infection or pathogenicity |
Jan. 23, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7052689 |
Method for producing therapeutically suitable glutaminase |
May. 30, 2006 |
| 7029684 |
Antigenic composition of a Pseudomonas aeruginosa |
Apr. 18, 2006 |
| 7018636 |
Vaccine against Gram-negative bacterial infections |
Mar. 28, 2006 |
| 6951652 |
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
Oct. 4, 2005 |
| 6942858 |
Compositions containing bacteriophages and methods of using bacteriophages to treat infections |
Sep. 13, 2005 |
| 6936447 |
Autoinducer molecule |
Aug. 30, 2005 |
| 6936263 |
Th1 inducing natural adjuvant for heterologous antigens |
Aug. 30, 2005 |
| 6905692 |
Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof |
Jun. 14, 2005 |
| 6872398 |
Conjugate vaccine against gram-negative bacterial infections |
Mar. 29, 2005 |
| 6793925 |
Pseudomycin natural products |
Sep. 21, 2004 |
| 6767545 |
Pseudomonas treatment composition and method |
Jul. 27, 2004 |
| 6723326 |
Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
Apr. 20, 2004 |
| 6696064 |
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-based immunotoxins during therapy |
Feb. 24, 2004 |
| 6645506 |
Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
Nov. 11, 2003 |
| 6630147 |
Pseudomycin natural products |
Oct. 7, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6541007 |
Vaccine for Pseudomonas aeruginosa |
Apr. 1, 2003 |
| 6531133 |
Pseudomonas exotoxin-myelin basic protein chimeric proteins |
Mar. 11, 2003 |
| 6426075 |
Protease-activatable pseudomonas exotoxin A-like proproteins |
Jul. 30, 2002 |
| 6423513 |
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins |
Jul. 23, 2002 |
| 6395282 |
Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
May. 28, 2002 |
| 6342233 |
Pseudomonas treatment composition and method |
Jan. 29, 2002 |
| 6309651 |
Method of and compositions for immunization with the pseudomonas V antigen |
Oct. 30, 2001 |
| 6300102 |
Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
Oct. 9, 2001 |
| 6270777 |
Conserved metalloprotease epitopes |
Aug. 7, 2001 |
| 6221386 |
Use of virulence factors of pathogens to improve liposomal delivery of therapeutic agents |
Apr. 24, 2001 |
| 6183756 |
Methods for prevention and/or treatment of thrombocytopenia |
Feb. 6, 2001 |
| 6121296 |
Transition-state inhibitors for nucleoside hydrolase and transferase reactions |
Sep. 19, 2000 |
| 6083928 |
Skin healing method |
Jul. 4, 2000 |
| 6045805 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Apr. 4, 2000 |
| 6007818 |
Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent |
Dec. 28, 1999 |
| 5997881 |
Method of making non-pyrogenic lipopolysaccharide or A |
Dec. 7, 1999 |
| 5955090 |
Immunogenic hybrid protein OprF-OprI derived from Pseudomonas aeruginosa membrane proteins |
Sep. 21, 1999 |
| 5951987 |
Polysaccharide vaccine to enhance immunity against brucellosis |
Sep. 14, 1999 |
| 5906826 |
Method of inducing an immune response in a young animal |
May. 25, 1999 |
| 5861163 |
Process for preparing a vaccine against pseudomonas aeruginosa using attenuated strains |
Jan. 19, 1999 |
| 5853738 |
Methods for treatment of human immunodeficiency virus infection with pseudomonas phosphoaminolipid extract |
Dec. 29, 1998 |
|
|
|
